Activity of tafasitamab in combination with rituximab in subtypes of aggressive lymphoma

Patra-Kneuer, M; Chang, GM; Xu, WD; Augsberger, C; Grau, M; Zapukhlyak, M; Ilieva, K; Landgraf, K; Mangelberger-Eberl, D; Yousefi, K; Berning, P; Kurz, KS; Ott, G; Klener, P; Khandanpour, C; Horna, P; Schanzer, J; Steidl, S; Endell, J; Heitmüller, C; Lenz, G

Lenz, G (通讯作者)，Univ Hosp Munster, Dept Med Hematol Oncol & Pneumol A, Munster, Germany.

FRONTIERS IN IMMUNOLOGY, 2023; 14 ():

Abstract

BackgroundDespite recent advances in the treatment of aggressive lymphomas, a significant fraction of patients still succumbs to their disease. Thus, ......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索